Integra Lifesciences Holdings (STU:IL3) Net Change in Cash : €-57 Mil (TTM As of Sep. 2024)

View and export this data going back to . Start your Free Trial

What is Integra Lifesciences Holdings Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Integra Lifesciences Holdings's Net Change in Cash for the three months ended in Sep. 2024 was €-0 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Sep. 2024 was €-57 Mil.

Integra Lifesciences Holdings Net Change in Cash Historical Data

The historical data trend for Integra Lifesciences Holdings's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Integra Lifesciences Holdings Net Change in Cash Chart

Integra Lifesciences Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Change in Cash

Get a 7-Day Free Trial

54.07

222.97

38.31

-53.61

-165.30

Integra Lifesciences Holdings Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Net Change in Cash	Get a 7-Day Free Trial															-33.23	2.45	290.26	-349.93	-0.07

Integra Lifesciences Holdings Net Change in Cash Calculation

Integra Lifesciences Holdings's Net Change in Cash for the fiscal year that ended in Dec. 2023 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	128.339	+	-86.361	+	-210.841	+	3.566
	=	-165

Integra Lifesciences Holdings's Net Change in Cash for the quarter that ended in Sep. 2024

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= 20.259 + -9.367 + -17.943 + 6.98

= -0

Net Change in Cash for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-57 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Integra Lifesciences Holdings Net Change in Cash Related Terms
Thank you for viewing the detailed overview of Integra Lifesciences Holdings's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Integra Lifesciences Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Integra Lifesciences Holdings Corp (STU:IL3) » Definitions » Net Change in Cash

Comparable Companies

RXST NVCR TNDM INMD ATEC AHCO CNMD IRTC UFPT ESTA ABT SYK BSX MDT XTER:SHL SZSE:300760 EW DXCM XAMS:PHIA ZBH

Traded in Other Exchanges

IART:USA IL3:Germany

Address

1100 Campus Road, Princeton, NJ, USA, 08540

Website

https://www.integralife.com

Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.

Integra Lifesciences Holdings Headlines

No Headlines